Enhanced antitumor activity of irofulven in combination with irinotecan in pediatric solid tumor xenograft models Michael H. WooJennifer K. PetersonPeter J. Houghton Original Article 16 October 2004 Pages: 411 - 419
Uptake of irinotecan metabolite SN-38 by the human intestinal cell line Caco-2 Tatsuya ItohShirou ItagakiKen Iseki Original Article 23 November 2004 Pages: 420 - 424
Antitumor activity of albendazole against the human colorectal cancer cell line HT-29: in vitro and in a xenograft model of peritoneal carcinomatosis Mohammad H. PourgholamiJaved AkhterDavid L. Morris Original Article 23 November 2004 Pages: 425 - 432
Development of a pharmacokinetic limited sampling model for temozolomide and its active metabolite MTIC Mark N. KirsteinJohn C. PanettaClinton F. Stewart Original Article 26 January 2005 Pages: 433 - 438
Hypericin—an inhibitor of proteasome function F PajonkJ ScholberB Fiebich Original Article 26 January 2005 Pages: 439 - 446
In vivo antitumor activity by 2′,4′-dihydroxy-6′-methoxy-3′,5′-dimethylchalcone in a solid human carcinoma xenograft model Chun-Lin YeJian-Wen LiuFeng Qian Original Article 22 January 2005 Pages: 447 - 452
A phase I, dose-finding study of irinotecan (CPT-11) short i.v. infusion combined with fixed dose of 5-fluorouracil (5-FU) protracted i.v. infusion in adult patients with advanced solid tumours Javier SastreLuis Paz-AresEduardo Díaz-Rubio Original Article 26 October 2004 Pages: 453 - 460
EM012, a microtubule-interfering agent, inhibits the progression of multidrug-resistant human ovarian cancer both in cultured cells and in athymic nude mice Jun ZhouMin LiuHarish C. Joshi Original Article 03 February 2005 Pages: 461 - 465
Phase I trial of weekly docetaxel with a 4-weekly cisplatin administration in patients with advanced gastric carcinoma Aristides PolyzosKonstantinos SyrigosVassilios Georgoulias Original Article 20 January 2005 Pages: 466 - 470
Endoxifen (4-hydroxy-N-desmethyl-tamoxifen) has anti-estrogenic effects in breast cancer cells with potency similar to 4-hydroxy-tamoxifen Young Chai LimZeruesenay DestaTodd C. Skaar Original Article 01 February 2005 Pages: 471 - 478
Effects of docetaxel on antigen presentation-related functions of human monocyte-derived dendritic cells Hiroshi NakashimaAkira TasakiMitsuo Katano Original Article 23 February 2005 Pages: 479 - 487
Pharmacokinetics of low-dose doxorubicin and metabolites in patients with AIDS-related Kaposi sarcoma M. JoergerA. D. R. HuitemaJ. H. Beijnen Original Article 23 February 2005 Pages: 488 - 496
Phase I study of the novel taxane CT-2103 in patients with advanced solid tumors Maria Luisa VeroneseKeith FlahertyPeter J. O’Dwyer Original Article 12 February 2005 Pages: 497 - 501
Secretory transport of irinotecan metabolite SN-38 across isolated intestinal tissue Shirou ItagakiYoshinobu SumiKen Iseki Short Communication 12 February 2005 Pages: 502 - 506
Significant induction of cyclophosphamide and thiotepa metabolism by phenytoin Milly E. de JongeAlwin D. R. HuitemaSjoerd Rodenhuis Short Communication 01 February 2005 Pages: 507 - 510